Sinocare progresses share repurchase program, buys 1.66% of capital

Sinocare Bio-sensing Inc. announced the progress of its share repurchase program as of November 30, 2025. The company has cumulatively repurchased 9,319,800 shares through its dedicated securities account via centralized bidding, representing 1.66% of its current total share capital.

The shares were acquired at a maximum price of CNY 21.39 per share and a minimum price of CNY 17.73 per share. The total transaction amount for the repurchase reached CNY 184,132,547.34, excluding transaction fees. This repurchase activity aligns with the company's previously approved plan and relevant laws and regulations.

The repurchase plan, initially approved on February 20, 2025, allows for the repurchase of shares using proprietary funds and bank repurchase-specific loans, with a total amount ranging from CNY 150,000,000 to CNY 300,000,000. The maximum repurchase price was adjusted to CNY 33.78 per share following the implementation of the 2024 annual equity distribution plan.